Magnesium-substituted hydroxyapatites

Details Magnesium-substituted hydroxyapatites Magnesium-substituted hydroxyapatites

2005-07-26

2005-07-26

Levy, Neil S. (Department: 1616)

Drug, bio-affecting and body treating compositions

Inorganic active ingredient containing

Phosphorus or phosphorus compound

C424S604000

Reexamination Certificate

active

06921544

ABSTRACT:
A stable, phase-pure magnesium-substituted crystalline hydroxyapatite containing from about 2.0 to about 29 wt % magnesium, wherein at least 75 wt % of the magnesium content is substituted for calcium ions in the hydroxyapatite lattice structure.

REFERENCES:
patent: 4097935 (1978-07-01), Jarcho
patent: 5830480 (1998-11-01), Ducheyne et al.
patent: 6027742 (2000-02-01), Lee et al.
patent: 97/17285 (1997-05-01), None
patent: 99/32400 (1999-07-01), None
patent: WO00/03747 (2000-01-01), None
Yaoukawa et al. Preparation—Mg-Cahae J. Mater. Chem. 6(8) p. 1401-1405 '96.
Bertoni et al., “Nanocrystals of magnesium and fluoride substituted hydroxyapatite,” J. Inorg. Biochem., 72 (1):29-35 (1998).
Bigi et al., “Magnesium Influence on Hydroxyapatite Crystallization,”J. Inorg. Biochem., 49, 69-78 (1993).

Affiliated with

Also associated with

Rating

Magnesium-substituted hydroxyapatites does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Magnesium-substituted hydroxyapatites, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Magnesium-substituted hydroxyapatites will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3398836